Presentation, Treatment, and Outcome of Survivors of In-Hospital Versus Out-of-Hospital Sudden Cardiac Arrest.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 29 11 2019
revised: 10 01 2020
accepted: 15 01 2020
pubmed: 26 2 2020
medline: 4 8 2020
entrez: 26 2 2020
Statut: ppublish

Résumé

We examined the baseline characteristics, rates of implantable cardioverter defibrillator implantation, and long-term all-cause mortality for survivors of in-hospital (IHSCA) versus out-of-hospital (OHSCA) sudden cardiac arrest (SCA). A total of 1,433 SCA survivors (807 IHSCA and 626 OHSCA) from 2002 to 2012 were followed through February 2017. Baseline characteristics and potential triggers of SCA, including significant electrolyte and metabolic abnormalities and acute myocardial infarction and ischemia, were collected. Adjusted survival analyses were performed using a multivariate Cox model. The presence of SCA triggers was similar between IHSCA and OHSCA patients (39% vs 35%, p = 0.3), but OHSCA was more likely associated with cardiac ischemia and drug abuse, whereas IHSCA was more associated with new antiarrhythmic drugs (p <0.05). OHSCA survivors were more likely to receive an implantable cardioverter defibrillator (38% vs 18%, p <0.001). Over a median follow-up of 3.6 years, 674 (47%) patients died. After adjusting for unbalanced baseline characteristics, survival was similar between IHSCA and OHSCA survivors (hazard ratio 1.1, 95% confidence interval 0.9 to 1.3, p = 0.4). In conclusion, survivors of IHSCA and OHSCA differed in baseline characteristic, potential SCA triggers, and treatment interventions but their adjusted survival was comparable.

Identifiants

pubmed: 32093953
pii: S0002-9149(20)30048-5
doi: 10.1016/j.amjcard.2020.01.007
pii:
doi:

Substances chimiques

Anti-Arrhythmia Agents 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1137-1141

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Almut Troeller McDermott (AT)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Vincenzo B Polsinelli (VB)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Norman C Wang (NC)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Krishna Kancharla (K)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Aditya Bhonsale (A)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Sandeep K Jain (SK)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia.

Samir Saba (S)

The Heart and Vascular Institute and the Department of Medicine, University of Pittsburgh Medical Center, Falls Church, Virginia. Electronic address: sabas@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH